Table 4 Secondary outcome scores
|  | Experimental Group n = 35 | Control Group n = 39 | Between-group difference over time |
|---|---|---|---|
|  | Mean ± SD (out of 10) | Mean ± SD (out of 10) | Mean (95 % CI), ES (95 % CI) |
Baseline  Self-efficacy  HRQoL | 5.83 ± 2.57 0.36 ± 0.34 | 5.92 ± 2.24 0.38 ± 0.32 |  |
Week 6  Self-efficacy  HRQoL | 7.36 ± 2.33* 0.65 ± 0.31 | 5.73 ± 1.96 0.44 ± 0.30 | 1.72(0.42, 3.0), ES = 0.76(0.28, 1.22) 0.23(0.6, 0.4), ES = 0.69(0.21, 1.15) |
Week 12  Self-efficacy  HRQoL | 6.95 ± 2.30 0.60 ± 0.32** | 5.51 ± 2.00 0.36 ± 0.35 | 1.53 (0.38, 2.7), ES = 0.67(0.3, 1.13) 0.26(0.06, 0.46), ES = 0.71(0.24, 1.18) |
Month 6  Self-efficacy  HRQoL | 7.19 ± 2.12 0.55 ± 0.34 | 6.00 ± 1.93 0.37 ± 0.34 | 1.28(0.32, 2.2), ES = 0.59(0.12, 1.05) 0.2(0.05, 0.35), ES = 0.53(0.06, 0.99) |